MYGN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 5.83 USD -4.43% Market Closed

Market Cap: $550.6m

	Myriad Genetics Inc NASDAQ:MYGN	US
	Chocoladefabriken Lindt & Spruengli AG OTC:CHLSY	CH
N	Netscout Systems Inc F:NSZ	US
A	Amphenol Corp XMUN:XPH	US
	Essity AB (publ) F:ESWB	SE
T	Thai Vegetable Oil PCL SET:TVO	TH
C	Carnival Corp LSE:0EV1	US
	Snam SpA MIL:SRG	IT
K	Kulicke and Soffa Industries Inc F:KU1	SG
G	General Mills Inc LSE:0R1X	US
	Triumph New Energy Co Ltd F:LUG	CN
	Park Hotels & Resorts Inc NYSE:PK	US
	Getlink SE F:TNU	FR
N	Nampak Ltd JSE:NPK	ZA
A	Asics Corp OTC:ASCCY	JP
	Azienda Bresciana Petroli Nocivelli SpA F:9UZ	IT
M	Merck & Co Inc VSE:MRK	US
N	Newmont Corporation F:NMM	US

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

68% > 70%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-26% > -8%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-32%

Declining Net Margin

-36% > -48%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-17% > -3%

Negative ROE

-77%

Negative 3Y Average ROE

Negative 3Y Average ROIC